| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |